Regenerative medicine for digestive fistulae therapy : benefits, challenges and promises of stem/stromal cells and emergent perspectives via their extracellular vesicles - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Advanced Drug Delivery Reviews Année : 2021

Regenerative medicine for digestive fistulae therapy : benefits, challenges and promises of stem/stromal cells and emergent perspectives via their extracellular vesicles

Résumé

Despite current management strategies, digestive fistulae remain extremely debilitating complications associated with significant morbidity and mortality, generating a need to develop innovative therapies in these indications. A number of clinical trials and experimental studies have thus investigated the potential of stem/stromal cells (SCs) or SC-derived extracellular vesicles (EVs) administration for post-surgical and Crohn's-associated fistulae. This review summarizes the physiopathology and current standards-of-care for digestive fistulae, along with relevant evidence from animal and clinical studies regarding SC or EV treatment for post-surgical digestive fistulae. Additionally, existing preclinical models of fistulizing Crohn's disease and results of SC therapy trials in this indication will be presented. The optimal formulation and administration protocol of SC therapy products for gastrointestinal fistula treatment and the challenges for a widespread use of darvadstrocel (Alofisel) in clinical practice will be discussed. Finally, the potential advantages of EV therapy and the obstacles towards their clinical translation will be introduced.
Fichier principal
Vignette du fichier
0000173762_001.PDF (24.64 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03415371 , version 1 (04-11-2021)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Anna C. Sebbagh, Boris Rosenbaum, Guillaume Péré, Hadrien Alric, Arthur Berger, et al.. Regenerative medicine for digestive fistulae therapy : benefits, challenges and promises of stem/stromal cells and emergent perspectives via their extracellular vesicles. Advanced Drug Delivery Reviews, 2021, 179, pp.113841. ⟨10.1016/j.addr.2021.113841⟩. ⟨hal-03415371⟩
41 Consultations
195 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More